![](https://d3ilqtpdwi981i.cloudfront.net/COkC4_XhWwCbQInwsjNcDdfM6l4=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/df/26/11/df261180-50cf-4232-bc9c-bd64c029f9cc/thumbnail_85b032ef-d2e2-4c03-b640-c14c52a7a6e2.jpg)
Other
Anti-cancer Drug Screening of Dual Tubulin and Hsp27 Inhibitors with 2D and 3D Lung Cancer Cell Assays
Undergraduate Research Posters 2012
Description
Cancer is the leading cause of death worldwide. The current treatment options available for lung cancer are limited and have drawbacks such as poor bioavailability, numerous side effects, poor efficacy and drug resistance. 3D model serve as a novel approach for drug screening purposes and the evaluation of compounds in the platform can help identify potent compounds for further in vivo xenograft studies.
Publication Date
9-6-2012
Disciplines
Citation Information
Janine Maria Naim and Rati Lama. "Anti-cancer Drug Screening of Dual Tubulin and Hsp27 Inhibitors with 2D and 3D Lung Cancer Cell Assays" (2012) Available at: http://works.bepress.com/ratilama/1/
Student Researchers: Janine M. Naim; Rati Lama
Faculty Advisor: Bin Su, Ph.D.